NEUROFIT: software for fitting Hodgkin-Huxley models to voltage-clamp data.

J Neurosci Methods

Department of Mathematics and Statistics, Biomathematics Research Centre, University of Canterbury, Private Bag 4800, Christchurch, New Zealand.

Published: December 2002

I introduce publicly available software for accurate fitting of Hodgkin-Huxley models to voltage-clamp data. I describe the model and non-linear fitting procedure employed by the software and compare its results with the usual method of fitting such models using potassium A-current data from a pyloric dilator cell of the lobster Panulirus interruptus and sodium current data from an electrocyte cell of the electric fish Sternopygus macrurus. The set of parameter values for the model determined by this software yield current traces that are substantially closer to the observed data than those determined from the usual fitting method. This improvement is due to the fact that the software fits all of the parameters simultaneously utilizing all of the data rather than fitting steady-state and time constant parameters disjointly using peak currents and portions of the rising and falling phases. I analyze the convergence properties of the software's fitting algorithm using simulated data showing that accurate parameter values are obtained for most of the parameters using any reasonable initial values. The software also incorporates a linear pre-estimation procedure to help in determining reasonable initial values for the full non-linear algorithm. I illustrate and discuss some of the inadequacies of voltage-clamp data.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0165-0270(02)00227-3DOI Listing

Publication Analysis

Top Keywords

voltage-clamp data
12
fitting hodgkin-huxley
8
hodgkin-huxley models
8
models voltage-clamp
8
data
8
parameter values
8
reasonable initial
8
initial values
8
fitting
7
software
5

Similar Publications

Neuropeptides are inter-cellular signaling molecules occurring throughout animals. Most neuropeptides bind and activate G-protein coupled receptors, but some also activate ionotropic receptors (or "ligand-gated ion channels"). This is exemplified by the tetra-peptide H-Phe-Met-Arg-Phe-NH (FMRFa), which activates mollusc and annelid FMRFa-gated sodium channels (FaNaCs) from the trimeric degenerin/epithelial sodium channel superfamily.

View Article and Find Full Text PDF

Do Pulmonary Ionocytes Absorb Chloride or Secrete Chloride?

Am J Physiol Cell Physiol

December 2024

Department of Internal Medicine and Pappajohn Biomedical Institute Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, USA.

Pulmonary ionocytes express high levels of cystic fibrosis transmembrane conductance regulator (CFTR) channels. When studied using the short-circuit current technique, ionocytes produce CFTR-dependent short-circuit currents consistent with Cl secretion. However, when studied without a voltage-clamp, data indicate that ionocytes absorb Cl.

View Article and Find Full Text PDF
Article Synopsis
  • Myh1 is identified as a mouse gene linked to deafness, with its role in the auditory system still unclear; knockout mice show significant hearing impairment and abnormal hair cell function.
  • Research shows that MYH1 variants in humans contribute to non-progressive hearing loss, with some individuals also experiencing osteopenia.
  • Structural and functional analysis indicates that MYH1 variants disrupt regular activity in outer hair cells, highlighting the gene's essential role in hearing and its genetic connection to hearing loss in affected families.
View Article and Find Full Text PDF

Objective: N-methyl-D-aspartate receptors are glutamate-gated ion channels that play a crucial role in brain function. Numerous inherited or de novo variants in the GRIN2A gene, encoding the GluN2A subunit of the receptor, have been identified in patients with epilepsy. In addition, it is worth noting that GRIN2A variants exhibit a strong correlation with epilepsy-aphasia syndromes, a group of age-dependent epileptic, cognitive, and language disorders with a characteristic electroencephalographic pattern.

View Article and Find Full Text PDF
Article Synopsis
  • Quetiapine is an atypical antipsychotic used to treat schizophrenia and depression, and its effect may be linked to inhibiting HCN channels.
  • Research showed that norquetiapine, a major active metabolite of quetiapine, selectively inhibits HCN1 channels, altering their activation and slowing their function without affecting closing kinetics.
  • These findings suggest that HCN channels are important targets for norquetiapine, providing insight into how quetiapine works therapeutically and opening doors for new drug development targeting HCN channels.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!